Simon Quick Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Simon Quick Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,531	Closed	-$138K	–	402
2022 Q1	$138K	Buy	1,531 +593	+63%	+$54.8K	0.04%	125
2021 Q4	$105K	Hold	938	–	–	0.03%	157
2021 Q3	$117K	Hold	938	–	–	0.03%	154
2021 Q2	$127K	Hold	938	–	–	0.03%	131
2021 Q1	$127K	Sell	938 -181	-16%	-$27.1K	0.04%	129
2020 Q4	$158K	Buy	1,119 +768	+219%	+$98.4K	0.05%	120
2020 Q3	$39K	Hold	351	–	–	0.01%	221
2020 Q2	$39K	Buy	351 +85	+32%	+$8.37K	0.01%	219
2020 Q1	$21K	Sell	266 -28	-10%	-$2.48K	0.01%	281
2019 Q4	$28K	Hold	294	–	–	0.01%	296
2019 Q3	$22K	Hold	294	–	–	0.01%	240
2019 Q2	$25.8K	Hold	294	–	–	0.01%	164
2019 Q1	$27K	Hold	294	–	–	0.01%	273
2018 Q4	$21K	Hold	294	–	–	0.01%	250
2018 Q3	$28K	Hold	294	–	–	0.01%	211
2018 Q2	$27K	Hold	294	–	–	0.01%	231
2018 Q1	$26K	Hold	294	–	–	0.01%	203
2017 Q4	$27K	Sell	294 -1,279	-81%	-$107K	0.01%	282
2017 Q3	$136K	Buy	1,573 +400	+34%	+$32.1K	0.05%	164
2017 Q2	$91K	Hold	1,173	–	–	0.05%	99
2017 Q1	$81K	Buy	+1,173	New	+$78.8K	0.05%	130

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Simon Quick Advisors's XBI Position: Q2 2022 in Review

Simon Quick Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2022, closing a stake of 1,531 shares — an estimated $138K sold.

Simon Quick Advisors first reported a position in XBI in Q1 2017 and held it in 21 quarters. The position peaked at $158K in Q4 2020. 704 funds tracked by Wall St. Rank hold XBI as of Q2 2022.

Simon Quick Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2022 after selling out during the quarter.
Simon Quick Advisors sold 1,531 State Street SPDR S&P Biotech ETF shares in Q2 2022, an estimated $138K.
Simon Quick Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and held it in 21 quarters.
Simon Quick Advisors's State Street SPDR S&P Biotech ETF position peaked at $158K in Q4 2020.
704 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2022.

Based on Simon Quick Advisors's 13F filing for Q2 2022, filed 8 Aug 2022.